Fundraising FoxAmphora Medical
acquired by HologicMaple Grove, US · Founded 2011 · Delaware corporation · 4 known investors
Find your way into Amphora Medical
Sign up to see every warm intro you have to Amphora Medical
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Amphora Medical team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Acquired by Hologic May 2019 · terms undisclosed · source ↗
Amphora Medical developed a minimally invasive, cystoscopic radiofrequency ablation device (Selective Bladder Denervation System) to treat overactive bladder syndrome in women.
Founders & leadership
Board
Investors · 4
How we know: Baird Capital's portfolio page · a partner's Signal profile · funding news · press coverage · Not right? Tell us
How we know: F-Prime Capital's portfolio page · a partner's Signal profile · board seat on SEC Form D · funding news · press coverage · Not right? Tell us
How we know: Longitude Capital's portfolio page · funding news · press coverage · Not right? Tell us
How we know: funding news · press coverage · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$23.8M disclosed across 2 rounds · 2013–2017
▶$11MraisedJul 2017 · 12 investors · Other Health CareRule 506(b)
- Thomas ThalerDirector
- Thomas V. RessemannExecutive Officer, Director
- Nicole J. WalkerDirector
- Marc GallettiDirector
- Chris OwensDirector
- Ketan PatelDirector
- Offering amount
- $35.5M
- Amount sold
- $11M
- Minimum investment
- $5.1K
- Sales commissions
- $700K
- Placement agents
- Aquilo Partners, L.P.
- First sale
- Jul 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$12.8MraisedJul 2015 · 8 investors · Other Health CareRule 506(b)
- Michael LiangDirector
- Dan SachsDirector
- Robert WeisskoffDirector
- Tom RessemannExecutive Officer, Director
- Offering amount
- $12.8M
- Amount sold
- $12.8M
- Proceeds to insiders
- $768K
- First sale
- May 2013
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Amphora Medical do?
- Amphora Medical developed a minimally invasive, cystoscopic radiofrequency ablation device (Selective Bladder Denervation System) to treat overactive bladder syndrome in women.
- Who are Amphora Medical's investors?
- Amphora Medical's investors include Baird Capital, F-Prime Capital, Longitude Capital, HBM Healthcare Investments.
- How much funding has Amphora Medical raised?
- Amphora Medical has disclosed $23.8M raised across 2 rounds.
- Who acquired Amphora Medical?
- Amphora Medical was acquired by Hologic.
- Where is Amphora Medical headquartered?
- Amphora Medical is headquartered in Maple Grove, US.